Brind.

Jim Cramer and Loomis Sayles mentioned Novartis (NVS) stock in commentary and a Q1 2025 letter on July 21, 2025.

1 report, 1 independent Updated Jul 21

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Novartis

Keep exploring

The entities involved

Novartis
Swiss-American multinational pharmaceutical corporation
- ABB and Novartis proposed AI solutions for energy and community health in Shanghai, supported by Tan Su Shan.Fri 13:14
- The Nuclear Regulatory Commission proposes a draft radiation guide for Pluvicto, a drug manufactured by Novartis.Thu 14:29

Coverage

Newest first; wire copies grouped

Jul 21Insider MonkeyNovartis AG (NVS): Jim Cramer Wonders Whether Its CEO Is Leaving We recently published 8 Stocks That Jim Cramer Recently Talked About. Novartis AG (NYSE:NVS) is one of the stocks Jim Cramer recently